{
  "schemaVersion": 1,
  "organisationId": "O-5cbc830812a8476bad6422c12793131a",
  "slug": "croda-international",
  "name": "CRODA INTERNATIONAL",
  "updatedAt": "2026-10-04T14:53:08.423642Z",
  "sections": [
    {
      "type": "OVERVIEW",
      "text": "Croda International is a global specialty-ingredients company that applies science and technology to develop ingredients and solutions for consumer, life-sciences and industrial markets. Its three business areas are Consumer Care, Life Sciences and Industrial Specialties, with products serving areas such as beauty and personal care, pharmaceuticals, crop science and industrial applications. Croda describes its purpose as “Smart science to improve lives.” [P86284518][https://www.croda.com/en-gb/our-markets/consumer-care][https://www.croda.com/en-gb/our-markets/life-sciences][https://www.croda.com/en-gb/our-markets/industrial-specialties][https://www.croda.com/en-gb/about-us/our-purpose]\n\nFor FY2025, Croda reported sales of £1,699.4 million, across its three business areas: Consumer Care (£972.7 million), Life Sciences (£532.2 million) and Industrial Specialties (£194.5 million). [T12765638][T6725171] At year-end 2025, the company reported 5,954 employees and 91 locations in 36 countries, with revenue across Europe, the Middle East and Africa, North America, Latin America and Asia. [https://www.croda.com/mediaassets/files/corporate/annual-report-2025/sustainability-performance.pdf?hash=85369564281E38D87C9F8D63FD733DE3&la=en-GB][T6725171]\n[P86284518][T12765638][T6725171][T6725171][T6725171][T6725171][https://www.croda.com/en-gb/our-markets/consumer-care][https://www.croda.com/en-gb/our-markets/life-sciences][https://www.croda.com/en-gb/our-markets/industrial-specialties][https://www.croda.com/en-gb/about-us/our-purpose][https://www.croda.com/mediaassets/files/corporate/annual-report-2025/sustainability-performance.pdf?hash=85369564281E38D87C9F8D63FD733DE3&la=en-GB]",
      "updatedAt": "2026-10-04T14:53:08.423642Z"
    },
    {
      "type": "PRODUCTS",
      "text": "Croda’s products include specialty ingredients for beauty, personal care, home care and fragrance. Examples include Matrixyl® Neolide™, a peptide ingredient using encapsulation for gradual release for up to 15 days; Malvallin™, a botanical skincare active; Natrineo™ CR8, a naturally derived, PEG-free emulsifier for water-in-oil-in-water emulsions; and Crodabond™ CSN, a naturally derived hair-care emollient. [https://www.croda.com/en-gb/media-hub/news/general/croda-beauty-matrixyl-neolide] [https://www.croda.com/en-gb/media-hub/news/general/croda-strengthens-premium-beauty-pipeline-with-next-generation-skincare-active-malvallin] [https://www.croda.com/en-gb/media-hub/news/general/natrineo-cr8] [https://www.croda.com/en-gb/media-hub/news/general/crodabond-csn]\n\nLife Sciences products include pharmaceutical excipients and lipid-based drug-delivery technologies, as well as crop-protection formulation aids and seed-enhancement products. Super Refined™ Poloxamer 188 is used in bioprocessing, including to help protect cell cultures from shear stress. Atlox™ BS-50 is a powder delivery system for spore-forming microbes, while Atlox™ 4913 is a dispersant intended to stabilise crop-formulation dispersions and support consistent distribution of active ingredients. Avanti Research’s portfolio includes more than 2,000 lipids. [https://www.croda.com/en-gb/media-hub/news/general/super-refined-leek] [https://www.croda.com/en-gb/media-hub/news/general/croda-first-product-launch-specifically-focusing-on-the-biopesticide-market] [https://www.croda.com/en-gb/about-us/case-studies/investing-in-organic-expansion-in-crop-care] [https://www.croda.com/en-gb/media-hub/news/acquisitions-and-partners/croda-expands-advanced-drug-delivery-capabilities-through-novoarc-collaboration]\n\nIndustrial Specialties products include surfactants, textile and spin finishes, and CrodaTherm™ phase-change materials for thermal-energy storage and regulation, with applications including cold-chain logistics and personal cooling apparel. Croda also offers formulation and technical support, including product-selection and technical-document resources, application laboratories, customer innovation centres, training and workshops. [https://www.croda.com/en-gb/our-markets/industrial-specialties] [https://www.crodaindustrialspecialties.cn/zh-cn/resources/resource-finder/resource/22482-crodatherm-5] [https://www.croda.com/en-gb/media-hub/news/general/croda-and-inuteq] [https://www.crodabeauty.com/en-gb/resources/technical-library/resource-finder] [https://www.croda.com/mediaassets/files/corporate/annual-report-2025/croda-annual-report-2025.pdf]\n\nFor FY2025, Consumer Care represented approximately 57.2% of Group sales, Life Sciences 31.3%, and Industrial Specialties 11.4%, calculated from reported segment sales of £972.7m, £532.2m and £194.5m, respectively, against Group sales of £1,699.4m. [https://www.croda.com/mediaassets/files/corporate/annual-report-2025/croda-annual-report-2025.pdf]\n[https://www.croda.com/en-gb/media-hub/news/general/croda-beauty-matrixyl-neolide][https://www.croda.com/en-gb/media-hub/news/general/croda-strengthens-premium-beauty-pipeline-with-next-generation-skincare-active-malvallin][https://www.croda.com/en-gb/media-hub/news/general/natrineo-cr8][https://www.croda.com/en-gb/media-hub/news/general/crodabond-csn][https://www.croda.com/en-gb/media-hub/news/general/super-refined-leek][https://www.croda.com/en-gb/media-hub/news/general/croda-first-product-launch-specifically-focusing-on-the-biopesticide-market][https://www.croda.com/en-gb/about-us/case-studies/investing-in-organic-expansion-in-crop-care][https://www.croda.com/en-gb/media-hub/news/acquisitions-and-partners/croda-expands-advanced-drug-delivery-capabilities-through-novoarc-collaboration][https://www.croda.com/en-gb/our-markets/industrial-specialties][https://www.crodaindustrialspecialties.cn/zh-cn/resources/resource-finder/resource/22482-crodatherm-5][https://www.croda.com/en-gb/media-hub/news/general/croda-and-inuteq][https://www.crodabeauty.com/en-gb/resources/technical-library/resource-finder][https://www.croda.com/mediaassets/files/corporate/annual-report-2025/croda-annual-report-2025.pdf]",
      "updatedAt": "2026-10-04T14:53:08.423642Z"
    },
    {
      "type": "GEOGRAPHY",
      "text": "Croda’s FY2025 revenue was £1,699.4m: £685.1m from EMEA (40.3%), £426.5m from Asia (25.1%), £401.1m from North America (23.6%) and £186.7m from Latin America (11.0%). In H1 2026, revenue was £880.5m, with EMEA contributing £367.3m (41.7%), Asia £223.0m (25.3%), North America £193.9m (22.0%) and Latin America £96.3m (10.9%). Percentages are calculated from the reported regional revenue figures. [T6725171][T16416422]\n\nCroda’s FY2025 report lists manufacturing locations in the UK, France, Netherlands, Italy, Spain and Denmark; the US; Brazil, Argentina, Colombia and Mexico; Singapore, Japan, India, China, Indonesia, Malaysia and Korea; South Africa and Tunisia; and Australia. [P105720229] The company reports operations in 37 countries and 44 principal manufacturing sites, and lists more than 6,100 employees; the cited sources do not give a regional employee breakdown. [https://www.croda.com/en-gb/about-us/croda-at-a-glance][https://www.croda.com/en-gb/about-us] Regional examples include Singapore as Asia-Pacific headquarters, four manufacturing sites in North America, six sales offices in Latin America, and the UK global headquarters in Yorkshire. [https://www.croda.com/en-gb/about-us/where-we-operate/asia-pacific][https://www.croda.com/en-gb/about-us/where-we-operate/north-america][https://www.croda.com/en-gb/about-us/where-we-operate/latin-america/][https://www.croda.com/en-gb/about-us/where-we-operate/emea/united-kingdom] In March 2026, Croda announced a new manufacturing facility in Dahej, Gujarat, India. [https://www.croda.com/en-gb/media-hub/news/general/croda-opens-new-manufacturing-facility-in-dahej]\n[T6725171][T16416422][P105720229][https://www.croda.com/en-gb/about-us/croda-at-a-glance][https://www.croda.com/en-gb/about-us][https://www.croda.com/en-gb/about-us/where-we-operate/asia-pacific][https://www.croda.com/en-gb/about-us/where-we-operate/north-america][https://www.croda.com/en-gb/about-us/where-we-operate/latin-america/][https://www.croda.com/en-gb/about-us/where-we-operate/emea/united-kingdom][https://www.croda.com/en-gb/media-hub/news/general/croda-opens-new-manufacturing-facility-in-dahej]",
      "updatedAt": "2026-10-04T14:53:08.423642Z"
    },
    {
      "type": "SEGMENTS",
      "text": "Croda reports three global market-sector segments: Consumer Care, Life Sciences and Industrial Specialties. For FY2025, their reported revenues were £972.7m, £532.2m and £194.5m, respectively—approximately 57%, 31% and 11% of Group revenue of £1,699.4m. [P82354025][T11790721]\n\nConsumer Care includes consumer-focused ingredient businesses such as Beauty Care, Beauty Actives, and Fragrances & Flavours. [P38657954] Life Sciences serves pharma and agriculture markets, including Pharma, Crop Protection and Seed Enhancement; Seed Enhancement includes seed-coating systems and technologies intended to support germination, seed development and yields. [P112125313][P26567935][P80417104] Industrial Specialties is the third global market sector; company reporting describes targeted sales in this area to improve utilisation at shared production sites. [P46741315]\n\nThe latest interim presentation, for H1 2026, retains the same three segments. Rounded reported sales imply an approximate mix of 60% Consumer Care, 29% Life Sciences and 11% Industrial Specialties. [T16416436] Croda also reports revenue by geographic destination, but this is a separate view rather than an alternative set of reportable business segments. [T6725171]\n[P82354025][T11790721][T11790721][T11790721][T11790721][P38657954][P112125313][P26567935][P80417104][P46741315][T16416436][T16416436][T16416436][T16416436][T6725171]",
      "updatedAt": "2026-10-04T14:53:08.423642Z"
    },
    {
      "type": "HISTORY",
      "text": "Croda International was founded in Yorkshire in 1925 by entrepreneur George Crowe and chemist Henry Dawe. Its name combined their surnames, and its first product was lanolin refined from wool grease. In the 1930s, lanolin’s use as a rust preventative opened new engineering and automotive markets; during the Second World War, Croda supplied products including camouflage oils and insect repellents. [https://www.croda.com/en-gb/about-us/our-heritage] [https://www.croda.com/en-gb/about-us/our-heritage/our-timeline]\n\nCroda established a U.S. presence with Croda Inc. in New York in 1950 and diversified into areas including cosmetics. A major expansion came in 2006 with its acquisition of Uniqema from ICI. Steve Foots became Group Chief Executive in 2012, and in 2013 Croda became majority shareholder in China-based Sipo, securing its first manufacturing foothold in China. [https://www.croda.com/en-gb/about-us/where-we-operate/north-america/usa] [https://www.croda.com/en-gb/about-us/our-heritage] [https://www.croda.com/en-gb/about-us/leadership]\n\nIn 2020, Croda acquired Avanti Polar Lipids and Iberchem, extending its life-sciences and fragrances businesses. It sold most of its Performance Technologies and Industrial Chemicals businesses to Cargill in 2022, then completed the acquisition of Solus Biotech in 2023. Croda marked its centenary in 2025. [https://www.croda.com/en-gb/investors/acquisitions/strengthening-life-sciences-with-the-acquisition-of-avanti-polar-lipids] [https://www.croda.com/en-gb/investors/acquisitions/acquisition-of-iberchem-expands-reach-into-high-growth-fragrances-market] [https://www.croda.com/mediaassets/files/corporate/investor-result-downloads/2021/croda-agreement-to-sell-majority-of-ptic-announcement-final-22-dec-2021.pdf] [https://www.croda.com/en-gb/investors/acquisitions] [https://www.croda.com/en-gb/media-hub/news/general/croda-launches-animated-timeline-to-showcase-100-years-of-innovation]\n[https://www.croda.com/en-gb/about-us/our-heritage][https://www.croda.com/en-gb/about-us/our-heritage/our-timeline][https://www.croda.com/en-gb/about-us/where-we-operate/north-america/usa][https://www.croda.com/en-gb/about-us/leadership][https://www.croda.com/en-gb/investors/acquisitions/strengthening-life-sciences-with-the-acquisition-of-avanti-polar-lipids][https://www.croda.com/en-gb/investors/acquisitions/acquisition-of-iberchem-expands-reach-into-high-growth-fragrances-market][https://www.croda.com/mediaassets/files/corporate/investor-result-downloads/2021/croda-agreement-to-sell-majority-of-ptic-announcement-final-22-dec-2021.pdf][https://www.croda.com/en-gb/investors/acquisitions][https://www.croda.com/en-gb/media-hub/news/general/croda-launches-animated-timeline-to-showcase-100-years-of-innovation]",
      "updatedAt": "2026-10-04T14:53:08.423642Z"
    }
  ],
  "sources": [
    {
      "id": "P86284518",
      "href": "https://app.finbar.com/go?id=P86284518",
      "label": "CRODA INTERNATIONAL — Full financial report (2025 Y), p1",
      "documentId": "D-9bdba11b85944de08cf2ab61bcc18964",
      "page": 1
    },
    {
      "id": "https://www.croda.com/en-gb/our-markets/consumer-care",
      "href": "https://www.croda.com/en-gb/our-markets/consumer-care",
      "label": "www.croda.com"
    },
    {
      "id": "https://www.croda.com/en-gb/our-markets/life-sciences",
      "href": "https://www.croda.com/en-gb/our-markets/life-sciences",
      "label": "www.croda.com"
    },
    {
      "id": "https://www.croda.com/en-gb/our-markets/industrial-specialties",
      "href": "https://www.croda.com/en-gb/our-markets/industrial-specialties",
      "label": "www.croda.com"
    },
    {
      "id": "https://www.croda.com/en-gb/about-us/our-purpose",
      "href": "https://www.croda.com/en-gb/about-us/our-purpose",
      "label": "www.croda.com"
    },
    {
      "id": "T12765638",
      "href": "https://app.finbar.com/go?id=T12765638",
      "label": "CRODA INTERNATIONAL — Full financial report (2025 Y), p23",
      "documentId": "D-9bdba11b85944de08cf2ab61bcc18964",
      "page": 23
    },
    {
      "id": "T6725171",
      "href": "https://app.finbar.com/go?id=T6725171",
      "label": "CRODA INTERNATIONAL — Full financial report (2025 Y), p145",
      "documentId": "D-9bdba11b85944de08cf2ab61bcc18964",
      "page": 145
    },
    {
      "id": "https://www.croda.com/mediaassets/files/corporate/annual-report-2025/sustainability-performance.pdf?hash=85369564281E38D87C9F8D63FD733DE3&la=en-GB",
      "href": "https://www.croda.com/mediaassets/files/corporate/annual-report-2025/sustainability-performance.pdf?hash=85369564281E38D87C9F8D63FD733DE3&la=en-GB",
      "label": "www.croda.com"
    },
    {
      "id": "https://www.croda.com/en-gb/media-hub/news/general/croda-beauty-matrixyl-neolide",
      "href": "https://www.croda.com/en-gb/media-hub/news/general/croda-beauty-matrixyl-neolide",
      "label": "www.croda.com"
    },
    {
      "id": "https://www.croda.com/en-gb/media-hub/news/general/croda-strengthens-premium-beauty-pipeline-with-next-generation-skincare-active-malvallin",
      "href": "https://www.croda.com/en-gb/media-hub/news/general/croda-strengthens-premium-beauty-pipeline-with-next-generation-skincare-active-malvallin",
      "label": "www.croda.com"
    },
    {
      "id": "https://www.croda.com/en-gb/media-hub/news/general/natrineo-cr8",
      "href": "https://www.croda.com/en-gb/media-hub/news/general/natrineo-cr8",
      "label": "www.croda.com"
    },
    {
      "id": "https://www.croda.com/en-gb/media-hub/news/general/crodabond-csn",
      "href": "https://www.croda.com/en-gb/media-hub/news/general/crodabond-csn",
      "label": "www.croda.com"
    },
    {
      "id": "https://www.croda.com/en-gb/media-hub/news/general/super-refined-leek",
      "href": "https://www.croda.com/en-gb/media-hub/news/general/super-refined-leek",
      "label": "www.croda.com"
    },
    {
      "id": "https://www.croda.com/en-gb/media-hub/news/general/croda-first-product-launch-specifically-focusing-on-the-biopesticide-market",
      "href": "https://www.croda.com/en-gb/media-hub/news/general/croda-first-product-launch-specifically-focusing-on-the-biopesticide-market",
      "label": "www.croda.com"
    },
    {
      "id": "https://www.croda.com/en-gb/about-us/case-studies/investing-in-organic-expansion-in-crop-care",
      "href": "https://www.croda.com/en-gb/about-us/case-studies/investing-in-organic-expansion-in-crop-care",
      "label": "www.croda.com"
    },
    {
      "id": "https://www.croda.com/en-gb/media-hub/news/acquisitions-and-partners/croda-expands-advanced-drug-delivery-capabilities-through-novoarc-collaboration",
      "href": "https://www.croda.com/en-gb/media-hub/news/acquisitions-and-partners/croda-expands-advanced-drug-delivery-capabilities-through-novoarc-collaboration",
      "label": "www.croda.com"
    },
    {
      "id": "https://www.crodaindustrialspecialties.cn/zh-cn/resources/resource-finder/resource/22482-crodatherm-5",
      "href": "https://www.crodaindustrialspecialties.cn/zh-cn/resources/resource-finder/resource/22482-crodatherm-5",
      "label": "www.crodaindustrialspecialties.cn"
    },
    {
      "id": "https://www.croda.com/en-gb/media-hub/news/general/croda-and-inuteq",
      "href": "https://www.croda.com/en-gb/media-hub/news/general/croda-and-inuteq",
      "label": "www.croda.com"
    },
    {
      "id": "https://www.crodabeauty.com/en-gb/resources/technical-library/resource-finder",
      "href": "https://www.crodabeauty.com/en-gb/resources/technical-library/resource-finder",
      "label": "www.crodabeauty.com"
    },
    {
      "id": "https://www.croda.com/mediaassets/files/corporate/annual-report-2025/croda-annual-report-2025.pdf",
      "href": "https://www.croda.com/mediaassets/files/corporate/annual-report-2025/croda-annual-report-2025.pdf",
      "label": "www.croda.com"
    },
    {
      "id": "T16416422",
      "href": "https://app.finbar.com/go?id=T16416422",
      "label": "CRODA INTERNATIONAL — Press release (2026 H 1), p25",
      "documentId": "D-ac9bfb4b09824e9cbe89ca65199ec656",
      "page": 25
    },
    {
      "id": "P105720229",
      "href": "https://app.finbar.com/go?id=P105720229",
      "label": "CRODA INTERNATIONAL — Full financial report (2025 Y), p145",
      "documentId": "D-9bdba11b85944de08cf2ab61bcc18964",
      "page": 145
    },
    {
      "id": "https://www.croda.com/en-gb/about-us/croda-at-a-glance",
      "href": "https://www.croda.com/en-gb/about-us/croda-at-a-glance",
      "label": "www.croda.com"
    },
    {
      "id": "https://www.croda.com/en-gb/about-us",
      "href": "https://www.croda.com/en-gb/about-us",
      "label": "www.croda.com"
    },
    {
      "id": "https://www.croda.com/en-gb/about-us/where-we-operate/asia-pacific",
      "href": "https://www.croda.com/en-gb/about-us/where-we-operate/asia-pacific",
      "label": "www.croda.com"
    },
    {
      "id": "https://www.croda.com/en-gb/about-us/where-we-operate/north-america",
      "href": "https://www.croda.com/en-gb/about-us/where-we-operate/north-america",
      "label": "www.croda.com"
    },
    {
      "id": "https://www.croda.com/en-gb/about-us/where-we-operate/latin-america/",
      "href": "https://www.croda.com/en-gb/about-us/where-we-operate/latin-america/",
      "label": "www.croda.com"
    },
    {
      "id": "https://www.croda.com/en-gb/about-us/where-we-operate/emea/united-kingdom",
      "href": "https://www.croda.com/en-gb/about-us/where-we-operate/emea/united-kingdom",
      "label": "www.croda.com"
    },
    {
      "id": "https://www.croda.com/en-gb/media-hub/news/general/croda-opens-new-manufacturing-facility-in-dahej",
      "href": "https://www.croda.com/en-gb/media-hub/news/general/croda-opens-new-manufacturing-facility-in-dahej",
      "label": "www.croda.com"
    },
    {
      "id": "P82354025",
      "href": "https://app.finbar.com/go?id=P82354025",
      "label": "CRODA INTERNATIONAL — Full financial report (2025 Y), p139",
      "documentId": "D-9bdba11b85944de08cf2ab61bcc18964",
      "page": 139
    },
    {
      "id": "T11790721",
      "href": "https://app.finbar.com/go?id=T11790721",
      "label": "CRODA INTERNATIONAL — Full financial report (2025 Y), p145",
      "documentId": "D-9bdba11b85944de08cf2ab61bcc18964",
      "page": 145
    },
    {
      "id": "P38657954",
      "href": "https://app.finbar.com/go?id=P38657954",
      "label": "CRODA INTERNATIONAL — Full financial report (2025 Y), p29",
      "documentId": "D-9bdba11b85944de08cf2ab61bcc18964",
      "page": 29
    },
    {
      "id": "P112125313",
      "href": "https://app.finbar.com/go?id=P112125313",
      "label": "CRODA INTERNATIONAL — Full financial report (2025 Y), p32",
      "documentId": "D-9bdba11b85944de08cf2ab61bcc18964",
      "page": 32
    },
    {
      "id": "P26567935",
      "href": "https://app.finbar.com/go?id=P26567935",
      "label": "CRODA INTERNATIONAL — Full financial report (2025 Y), p32",
      "documentId": "D-9bdba11b85944de08cf2ab61bcc18964",
      "page": 32
    },
    {
      "id": "P80417104",
      "href": "https://app.finbar.com/go?id=P80417104",
      "label": "CRODA INTERNATIONAL — Full financial report (2025 Y), p32",
      "documentId": "D-9bdba11b85944de08cf2ab61bcc18964",
      "page": 32
    },
    {
      "id": "P46741315",
      "href": "https://app.finbar.com/go?id=P46741315",
      "label": "CRODA INTERNATIONAL — Full financial report (2025 Y), p27",
      "documentId": "D-9bdba11b85944de08cf2ab61bcc18964",
      "page": 27
    },
    {
      "id": "T16416436",
      "href": "https://app.finbar.com/go?id=T16416436",
      "label": "CRODA INTERNATIONAL — Presentation (2026 H 1), p11",
      "documentId": "D-db7ef5c02afa45fda19aff8b66fb7fd0",
      "page": 11
    },
    {
      "id": "https://www.croda.com/en-gb/about-us/our-heritage",
      "href": "https://www.croda.com/en-gb/about-us/our-heritage",
      "label": "www.croda.com"
    },
    {
      "id": "https://www.croda.com/en-gb/about-us/our-heritage/our-timeline",
      "href": "https://www.croda.com/en-gb/about-us/our-heritage/our-timeline",
      "label": "www.croda.com"
    },
    {
      "id": "https://www.croda.com/en-gb/about-us/where-we-operate/north-america/usa",
      "href": "https://www.croda.com/en-gb/about-us/where-we-operate/north-america/usa",
      "label": "www.croda.com"
    },
    {
      "id": "https://www.croda.com/en-gb/about-us/leadership",
      "href": "https://www.croda.com/en-gb/about-us/leadership",
      "label": "www.croda.com"
    },
    {
      "id": "https://www.croda.com/en-gb/investors/acquisitions/strengthening-life-sciences-with-the-acquisition-of-avanti-polar-lipids",
      "href": "https://www.croda.com/en-gb/investors/acquisitions/strengthening-life-sciences-with-the-acquisition-of-avanti-polar-lipids",
      "label": "www.croda.com"
    },
    {
      "id": "https://www.croda.com/en-gb/investors/acquisitions/acquisition-of-iberchem-expands-reach-into-high-growth-fragrances-market",
      "href": "https://www.croda.com/en-gb/investors/acquisitions/acquisition-of-iberchem-expands-reach-into-high-growth-fragrances-market",
      "label": "www.croda.com"
    },
    {
      "id": "https://www.croda.com/mediaassets/files/corporate/investor-result-downloads/2021/croda-agreement-to-sell-majority-of-ptic-announcement-final-22-dec-2021.pdf",
      "href": "https://www.croda.com/mediaassets/files/corporate/investor-result-downloads/2021/croda-agreement-to-sell-majority-of-ptic-announcement-final-22-dec-2021.pdf",
      "label": "www.croda.com"
    },
    {
      "id": "https://www.croda.com/en-gb/investors/acquisitions",
      "href": "https://www.croda.com/en-gb/investors/acquisitions",
      "label": "www.croda.com"
    },
    {
      "id": "https://www.croda.com/en-gb/media-hub/news/general/croda-launches-animated-timeline-to-showcase-100-years-of-innovation",
      "href": "https://www.croda.com/en-gb/media-hub/news/general/croda-launches-animated-timeline-to-showcase-100-years-of-innovation",
      "label": "www.croda.com"
    }
  ]
}
